전자동 혈액형 판정 시스템 시장 규모 : 기술별, 최종 사용자별, 지역별 및 예측별

Global Fully Automated Blood Grouping System Market Analysis

According to Verified Market Research, the Global Fully Automated Blood Grouping System Market size was valued at USD 1.39 Billion in 2025 and is projected to reach USD 2.14 Billion by 2033, growing at a CAGR of 8.50% from 2027 to 2033.

The Fully Automated Blood Grouping System Market is witnessing significant growth due to ongoing technological advancements, rising demand for high-throughput blood testing, and continuous improvements in healthcare infrastructure worldwide. The increasing incidence of blood-related disorders and infectious diseases is creating a greater need for accurate and reliable blood typing solutions. In addition, growing investments by healthcare institutions and government organizations to upgrade blood banks and laboratory facilities are further supporting the expansion of this market.

Global Fully Automated Blood Grouping System Market Definition

The Fully Automated Blood Grouping System Market represents the global sector focused on advanced laboratory equipment designed to automatically identify an individual's blood group and Rh factor with minimal manual involvement. These systems are commonly used in hospitals, blood banks, diagnostic laboratories, and research facilities to provide accurate and rapid blood typing, which is essential for safe blood transfusions, organ transplantation, prenatal screening, and other clinical diagnostic procedures. Fully automated systems combine robotics, specialized reagents, microplate or gel card technologies, and advanced software to perform blood typing efficiently, reduce human error, and improve overall laboratory productivity.

The increasing need for safe and dependable blood transfusion services is a major factor driving the adoption of fully automated blood grouping systems. The rising number of surgical procedures, trauma incidents, and chronic illnesses such as cancer and hematological disorders has significantly increased the demand for blood and blood products worldwide. Furthermore, growing awareness regarding transfusion safety and the implementation of strict regulatory standards for blood screening have encouraged healthcare organizations to adopt automated testing solutions to reduce the risk of incompatible transfusions.

Global Fully Automated Blood Grouping System Market Overview

Blood transfusions play a vital role in numerous medical procedures, including surgeries, trauma treatment, cancer therapies, and organ transplantation. Since errors in blood typing can cause serious transfusion reactions, precise blood grouping is a crucial part of clinical diagnostics. Fully automated blood grouping systems help minimize the possibility of human error by standardizing testing procedures and providing accurate and consistent results. This reliability is encouraging hospitals, diagnostic laboratories, and blood banks to increasingly implement automated blood typing technologies.

Another important factor contributing to market growth is the increasing number of surgical procedures and emergency medical cases worldwide. Rising incidents of road accidents, cardiovascular conditions, and complex medical treatments have significantly increased the demand for blood transfusions. As a result, blood banks and hospital laboratories are required to process a large number of samples within limited timeframes. Fully automated blood grouping systems provide high-throughput capabilities, allowing laboratories to conduct large volumes of blood typing tests rapidly and efficiently. These systems help optimize laboratory operations, reduce processing time, and improve overall efficiency, making them highly valuable for healthcare facilities managing growing patient demands.

The growing focus on minimizing laboratory errors and improving diagnostic precision is another key factor driving market growth. Traditional manual blood grouping methods can be labor-intensive and susceptible to inconsistencies caused by differences in technician expertise and handling procedures. Automated systems address these issues by standardizing the testing process, ensuring consistent and reliable results. This level of accuracy is especially important in critical care situations where quick and dependable blood typing is essential for timely transfusion decisions. As healthcare providers increasingly emphasize patient safety and high-quality care, the adoption of automated diagnostic technologies continues to accelerate.

However, fully automated blood grouping systems also involve certain challenges related to operational costs. These platforms require regular calibration, specialized reagents, and routine maintenance to maintain their accuracy and performance. Such ongoing expenses can create a financial burden for healthcare facilities. Laboratories must also purchase consumables and proprietary reagents that are often supplied by specific manufacturers, which can lead to dependence on particular vendors and higher long-term operational costs. For healthcare institutions operating under strict budget constraints, these recurring expenditures may discourage the transition from semi-automated or manual blood typing methods to fully automated systems.

Although automation decreases the amount of manual work required, these systems still need skilled personnel who are familiar with laboratory information systems, quality control standards, and equipment troubleshooting procedures. In many developing regions, there is a shortage of laboratory professionals with expertise in advanced diagnostic automation. This lack of adequately trained staff can limit the effective use of automated blood grouping systems and may discourage healthcare facilities from adopting these technologies.

Global Fully Automated Blood Grouping System Market: Segmentation Analysis

The Global Fully Automated Blood Grouping System Market is segmented based on Technology, End-user and Geography.

Global Fully Automated Blood Grouping System Market, By End User

Hospitals

Blood Banks

Diagnostic Laboratories

Research Institutes

Based on End-user, the market is segmented into Hospitals, Blood Banks, Diagnostic Laboratories, Research Institutes. Hospitals hold the dominant share in the Fully Automated Blood Grouping System Market because they require fast and dependable blood typing for procedures such as surgeries, trauma management, and emergency treatments. These healthcare facilities manage a large number of transfusion-related cases and need immediate compatibility testing to ensure patient safety. Fully automated systems improve laboratory efficiency by optimizing workflows, minimizing human errors, and delivering quicker results, making them highly valuable for hospital laboratories responsible for critical patient care and safe transfusion practices.

Global Fully Automated Blood Grouping System Market, By Technology

Gel Card Technology

Microplate Technology

Column Agglutination Technology

Based on Technology, the market is segmented into Gel Card Technology, Microplate Technology, Column Agglutination Technology. Gel card technology dominates the technology segment in the Fully Automated Blood Grouping System Market due to its high level of reliability, simple result interpretation, and strong compatibility with automated laboratory platforms. This method produces clear and stable reaction outcomes, which helps reduce the likelihood of human error during analysis. Many laboratories favor gel-based systems for immunohematology testing because they deliver consistent performance, enable efficient sample handling, and enhance accuracy in blood typing and antibody screening.

Global Fully Automated Blood Grouping System Market, By Geography

North America

Europe

Asia Pacific

Latin America

Middle East and Africa

On the basis of Geography, the global Fully Automated Blood Grouping System market is classified into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America holds a leading position in the Fully Automated Blood Grouping System Market, supported by its well-developed healthcare infrastructure, extensive use of laboratory automation, and strong focus on transfusion safety. Healthcare facilities in the region actively adopt advanced diagnostic technologies to improve the accuracy and efficiency of blood testing procedures. Furthermore, the presence of established blood banks, research organizations, and major medical technology companies further strengthens the demand for automated blood grouping systems across the region.

Key Players

The "Global Fully Automated Blood Grouping System Market" study report will provide valuable insight with an emphasis on the global market including some of the major players of the industry are Immucor, Hamilton Bonaduz AG, Diagnostic Grifols S.A., Ortho-Clinical Diagnostics, Beckman Coulter, Hybiome, Johnson & Johnson, WEGO, Zhongshan Bio-Tech, and Zhitong Biopharma among others.

Our market analysis offers detailed information on major players wherein our analysts provide insight into the financial statements of all the major players, product portfolio, product benchmarking, and SWOT analysis. The competitive landscape section also includes market share analysis, key development strategies, recent developments, and market ranking analysis of the above-mentioned players globally.

TABLE OF CONTENTS

1 INTRODUCTION OF THE GLOBAL FULLY AUTOMATED BLOOD GROUPING SYSTEM MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL FULLY AUTOMATED BLOOD GROUPING SYSTEM MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL FULLY AUTOMATED BLOOD GROUPING SYSTEM MARKET, BY END-USER

• 5.1 Overview
• 5.2 Hospitals
• 5.3 Blood Banks
• 5.4 Diagnostic Laboratories
• 5.5 Research Institutes

6 GLOBAL FULLY AUTOMATED BLOOD GROUPING SYSTEM MARKET, BY TECHNOLOGY

• 6.1 Overview
• 6.2 Gel Card Technology
• 6.3 Microplate Technology
• 6.4 Column Agglutination Technology

7 GLOBAL FULLY AUTOMATED BLOOD GROUPING SYSTEM MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Argentina
  • 7.5.3 Rest of Latin America
• 7.6 Middle East and Africa
  • 7.6.1 Saudi Arabia
  • 7.6.2 UAE
  • 7.6.3 South Africa
  • 7.6.4 Rest of Middle East and Africa

8 GLOBAL FULLY AUTOMATED BLOOD GROUPING SYSTEM MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies
• 8.4 Company Industry Footprint
• 8.5 Company Regional Footprint
• 8.6 Ace Matrix

9 COMPANY PROFILES

• 9.1 Immucor
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 Hamilton Bonaduz AG
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 Diagnostic Grifols S.A
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 Ortho-Clinical Diagnostics
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 Beckman Coulter
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Development
• 9.6 Hybiome
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Development
• 9.7 Johnson & Johnson
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Development
• 9.8 WEGO
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Development
• 9.9 Zhongshan Bio-tech
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Development
• 9.10 Others
  • 9.10.1 Overview
  • 9.10.2 Financial Performance
  • 9.10.3 Product Outlook
  • 9.10.4 Key Development

10 Appendix

• 10.1.1 Related Reports